Delivery Order SPE2DB24D3013-SPE2DB25FFMVE
Award Date
6/25/25
Potential Completion Date
6/26/25
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of 180 800-milligram delayed-release mesalamine tablets. The $6,145.71 contract has an ultimate completion date of June 11, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,143.47 firm-fixed-price contract is for the delivery of 180 units of 800 mg delayed-release mesalamine tablets, a medication used to treat gastrointestinal conditions. The contract has an ultimate completion date of October 20, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,705.97, is for the delivery of 120 tablets of the prescription drug Mesalamine delayed-release 1.2 gram. The contract is a firm-fixed price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 120 tablets of the medication Mesalamine Delayed-Release 1.2 gram, with a ceiling value of $2,180.50 and a completion date of June 5, 2025. The contract is not set aside for any special designation. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,396.75 firm fixed-price contract is for the delivery of 120 tablets of 1.2 gram Mesalamine, a medication used to treat certain gastrointestinal conditions. The contract has an ultimate completion date of April 10, 2025 and is not associated with any set-aside requirements. AmerisourceBergen holds a significant...
This is a delivery order award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Mesalamine 800 mg delayed-release (DR) tablets. The $1,946.81 firm-fixed-price contract has an ultimate completion date of August 19, 2024 and does not utilize a set-aside. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999 through December 2025 for delivering a...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order for the supply of 180 tablets of Mesalamine 800 mg delayed-release tablets. The contract, valued at $7,879.55, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency that provides medical supplies to military treatment facilities. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for $2,098.63 and is for the delivery of 120 units of the pharmaceutical product Mesalamine 1.2 grams. The contract is a firm fixed-price delivery order and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $2,978.92 firm fixed-price delivery order is for the supply of 120 tablets of 1.2 gram Mesalamine delayed-release tablets. The contract has an ultimate completion date of July 3, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 31, 2025 with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,485.32 firm fixed-price delivery order is for the supply of 120 tablets of the drug Mesalamine DR 1.2 GM. The contract has an ultimate completion date of April 4, 2025 and was awarded on April 3, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract held by AmerisourceBergen with the...